Neurotrophic factors in the therapy of diabetic neuropathy

American Journal of Medicine

Volumn 107, Issue 2 SUPPL. 2, 1999, Pages 34-42

  Apfel, Stuart C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; SOMATOMEDIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; RECOMBINANT NERVE GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C;

CONFERENCE PAPER; DIABETIC NEUROPATHY; HUMAN; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; SENSORY NERVE CELL; CLINICAL TRIAL; METABOLISM; REVIEW; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; CHICK EMBRYO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EMBRYO; HYPERALGESIA; MYALGIA; NERVE FIBER DEGENERATION; NEUROTROPISM; NONHUMAN; PERIPHERAL NERVE INJURY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RAT; SENSORY NEUROPATHY; SUBCUTANEOUS DRUG ADMINISTRATION;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CLINICAL TRIALS; DIABETIC NEUROPATHIES; HUMANS; NERVE GROWTH FACTORS; SOMATOMEDINS;

EID: 0032869840     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. Olsson Y. Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol (Berl). 10:1968;26-33.
2. Levi-Montalcini R., Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 116:1951;321-362.
3. Levi-Montalcini R., Angeletti P.U. Nerve growth factor. Physiol Rev. 48:1968;534-569.
4. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1:1982;549-553.
5. Ernfors P., Lee K.F., Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 368:1994;147-150.
6. Sendtner M., Holtmann B., Kolbeck R., et al. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 360:1992;757-759.
7. Leibrock J., Lottspeich F., Hohn A., et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
8. Ernfors P., Lee K.F., Kucera J., Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell. 77:1994;503-512.
9. Hory-Lee F., Russell M., Lindsay R.M., Frank E. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA. 90:1993;2613-2617.
10. Hallbook F., Ibanez C.F., Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron. 6:1991;845-858.
11. Berkemeier L.R., Winslow J.W., Kaplan D.R., et al. Neurotrophin-5 a novel neurotrophic factor that activates trk and trkB . Neuron. 7:1991;857-866.
12. Friedman B., Kleinfeld D., Ip N.Y., et al. BDNF and NT-4/5 exert neurotrophic influences on injured adult spinal motor neurons. J Neurosci. 15:1995;1044-1056.
13. Martin-Zanca D., Hughes S.H., Barbacid M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature. 319:1986;743-748.
14. Klein R., Nanduri V., Jing S.A., et al. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:1991;395-403.
15. Klein R., Lamballe F., Bryant S., Barbacid M. The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron. 8:1992;947-956.
16. Lamballe F., Klein R., Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell. 66:1991;967-979.
17. Johnson D., Lanahan A., Buck C.R., et al. Expression and structure of the human NGF receptor. Cell. 47:1986;545-554.
18. Herrmann J.L., Menter D.G., Hamada J., et al. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor melanoma p75 functions independently of trkA . Mol Biol Cell. 4:1993;1205-1216.
19. Anton E.S., Weskamp G., Reichardt L.F., Matthew W.D. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA. 91:1994;2795-2799.
20. Dobrowsky R.T., Werner M.H., Castellino A.M., et al. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 265:1994;1596-1599.
21. Carter B.D., Kaltschmidt C., Kaltschmidt B., et al. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75 [see comments]. Science. 272:1996;542-545.
22. Neely E.K., Beukers M.W., Oh Y., et al. Insulin-like growth factor receptors. Acta Paediatr Scand. [Suppl]. 372:1991;116-123.
23. Lewis M.E., Neff N.T., Contreras P.C., et al. Insulin-like growth factor-I potential for treatment of motor neuronal disorders . Exp Neurol. 124:1993;73-88.
24. Edwall D., Schalling M., Jennische E., Norstedt G. Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology. 124:1989;820-825.
25. Recio-Pinto E., Reichler M.M., Ishii D.N. Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci. 6:1986;1211-1219.
26. Near S.L., Whalen L.R., Miller J.A., Ishii D.N. Insulin-like growth factor II stimulates motor nerve regeneration. Proc Natl Acad Sci USA. 89:1992;11716-11720.
27. Glazner G.W., Lupien S., Miller J.A., Ishii D.N. Insulin-like growth factor II increases the rate of sciatic nerve regeneration in rats. Neuroscience. 54:1993;791-797.
28. Ishii D.N., Glazner G.W., Whalen L.R. Regulation of peripheral nerve regeneration by insulin-like growth factors. Ann N Y Acad Sci. 692:1993;172-182.
29. Ang L.C., Bhaumick B., Munoz D.G., et al. Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J Neurol Sci. 109:1992;168-172.
30. Engele J., Schubert D., Bohn M.C. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro role of mesencephalic glia . J Neurosci Res. 30:1991;359-371.
31. Lin L.F., Doherty D.H., Lile J.D., et al. GDNF a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons [see comments] . Science. 260:1993;1130-1132.
32. Jing S., Wen D., Yu Y., et al. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
33. Sanicola M., Hession C., Worley D., et al. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci USA. 94:1997;6238-6243.
34. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. [see comments]. Science1994;266:1062-1064. [Erratum published in Science1995;267:777.].
35. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. [see comments]. Science1994;266:1062-1064. [Erratum published in Science1995;267:777.].
36. Oppenheim R.W., Houenou L.J., Johnson J.E., et al. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF [see comments]. Nature. 373:1995;344-346.
37. Buj-Bello A., Buchman V.L., Horton A., et al. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron. 15:1995;821-828.
38. Kotzbauer P.T., Lampe P.A., Heuckeroth R.O., et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature. 384:1996;467-470.
39. Milbrandt J., de Sauvage F.J., Fahrner T.J., et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 20:1998;245-253.
40. Baloh R.H., Tansey M.G., Golden J.P., et al. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron. 18:1997;793-802.
41. Klein RD, Sherman D, Ho WH, et al. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature1997;387:717-721. [Erratum: Nature. 1998;392:210.].
42. Klein RD, Sherman D, Ho WH, et al. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature1997;387:717-721. [Erratum: Nature. 1998;392:210.].
43. Hellweg R., Hartung H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus a possible role for NGF in the pathogenesis of diabetic neuropathy . J Neurosci Res. 26:1990;258-267.
44. Hellweg R., Raivich G., Hartung H.D., et al. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol. 130:1994;24-30.
45. Jakobsen J., Brimijoin S., Skau K., et al. Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes. 30:1981;797-803.
46. Ordonez G., Fernandez A., Perez R., Sotelo J. Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice a possible etiological element of diabetic neuropathy . J Neurol Sci. 121:1994;163-166.
47. Faradji V., Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand. 81:1990;402-406.
48. Brewster W.J., Fernyhough P., Diemel L.T., et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors [see comments]. Trends Neurosci. 17:1994;321-325.
49. Anand P., Terenghi G., Warner G., et al. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med. 2:1996;703-707.
50. Tomlinson D.R., Fernyhough P., Diemel L.T. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes. 46:(suppl 2):1997;S43-S49.
51. Crosby S.R., Tsigos C., Anderton C.D., et al. Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy. Diabetologia. 35:1992;868-872.
52. Wuarin L., Guertin D.M., Ishii D.N. Early reduction in insulin-like growth factor gene expression in diabetic nerve. Exp Neurol. 130:1994;106-114.
53. Feldman E.L., Stevens M.J., Greene D.A. Pathogenesis of diabetic neuropathy. Clin Neurosci. 4:1997;365-370.
54. Apfel S.C., Arezzo J.C., Brownlee M., et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634:1994;7-12.
55. Fernyhough P., Diemel L.T., Hardy J., et al. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci. 7:1995;1107-1110.
56. Ishii D.N., Lupien S.B. Insulin-like growth factors protect against diabetic neuropathy effects on sensory nerve regeneration in rats . J Neurosci Res. 40:1995;138-144.
57. Zhuang H.X., Snyder C.K., Pu S.F., Ishii D.N. Insulin-like growth factors reverse or arrest diabetic neuropathy effects on hyperalgesia and impaired nerve regeneration in rats . Exp Neurol. 140:1996;198-205.
58. Petty B.G., Cornblath D.R., Adornato B.T., et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol. 36:1994;244-246.
59. Apfel S.C., Adornato B., Cornblath D., et al. Clinical trial of recombinant human nerve growth factor (rhNGF) in peripheral neuropathy. Neurology. 45:(suppl 4):1995;A278-A279.
60. Apfel S.C., Kessler J.A., Adornato B.T., et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology. 51:1998;695-702.